BriaCell Therapeutics Corp. Warrant
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BCTXW Company Description
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
BCTXW Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BCTXW Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BCTXW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BCTXW's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BCTXW in WallStreetBets Daily Discussion
BCTXW News
Recent insights relating to BCTXW
CNBC Recommendations
Recent picks made for BCTXW stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BCTXW
Corporate Flights
Flights by private jets registered to BCTXW
Our Analysis